Published in J Neural Transm Suppl on January 01, 1989
Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. Psychosom Med (2007) 1.00
Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa. J Psychiatry Neurosci (1994) 0.75
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol (2001) 3.05
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol (2001) 2.41
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol (1999) 1.97
Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today (1998) 1.82
Self-ignorance in the peripheral T-cell pool. Immunol Rev (1993) 1.73
Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69
Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol (1997) 1.56
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47
Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43
Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40
Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J Exp Med (1989) 1.35
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature (1999) 1.23
B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20
SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens (2006) 1.20
Antigen-specific CD8+ T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection. Eur J Immunol (1997) 1.18
Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev (1998) 1.10
Immunity or tolerance? That is the question for dendritic cells. Nat Immunol (2001) 1.09
Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur J Immunol (1994) 1.08
Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection. J Virol (2000) 1.07
Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol (1993) 1.04
A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol (2000) 1.01
A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol (2001) 1.01
Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc Natl Acad Sci U S A (1993) 1.00
Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.98
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.97
Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes. J Immunol (1989) 0.96
Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus. J Gen Virol (2000) 0.96
Deletion of high-avidity T cells by thymic epithelium. Proc Natl Acad Sci U S A (1995) 0.95
The threshold for autoimmune T cell killing is influenced by B7-1. Eur J Immunol (1998) 0.95
Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes (2001) 0.94
Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.93
The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.93
Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells. J Exp Med (1994) 0.90
Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses. Pharmacopsychiatry (1996) 0.90
Inhibition of naïve class I-restricted T cells by altered peptide ligands. Immunol Cell Biol (1999) 0.89
Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.87
Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines. Eur J Immunol (2000) 0.87
Peptide-induced deletion of CD8 T cells in vivo occurs via apoptosis in situ. Int Immunol (1997) 0.87
Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity. Novartis Found Symp (1998) 0.86
Down-modulation of CD8 beta-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. Cell Immunol (1997) 0.85
The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol Cell Biol (1999) 0.83
Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin. Pharmacol Biochem Behav (1984) 0.82
Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement. Pharmacopsychiatry (1999) 0.81
Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: amplification of the lytic potential by B7. J Immunol (1999) 0.81
Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics. Pharmacopsychiatry (1986) 0.80
Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry (1991) 0.80
Neophobia in spontaneous hypertensive (SHR) and normotensive control (WKY) rats. Behav Neural Biol (1985) 0.80
[Pharmacological research on maprotiline a new drug with antidepressive effects]. Boll Chim Farm (1973) 0.80
Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol (1998) 0.79
Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor. Int J Psychiatry Clin Pract (1999) 0.79
Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine. Pharmacopsychiatry (1991) 0.78
Medullary thymic epithelium induces tolerance to allogeneic major histocompatibility complex class I antigens. Transplant Proc (1993) 0.78
Effects of apomorphine, TL-99 and 3-PPP on yawning in rats. Neuropharmacology (1984) 0.78
Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants. Vaccine (2008) 0.78
Suppressant effect of REM sleep deprivation on neophobia in normal rats and in rats with selective DSP-4 induced damage of locus coeruleus neurons. Pharmacol Biochem Behav (1985) 0.78
Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112). Arzneimittelforschung (1984) 0.78
Onset of action under antidepressant treatment. Eur Psychiatry (1997) 0.78
Antidepressants and drug-metabolizing enzymes--expert group report. Acta Psychiatr Scand (1996) 0.78
Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin. Psychopharmacology (Berl) (1983) 0.78
T cell tolerance and autoimmunity. Ciba Found Symp (1997) 0.77
A new IFN-like cytokine, limitin, modulates the immune response without influencing thymocyte development. J Immunol (2001) 0.77
Inhibitory effects of propranolol and oxprenolol on excitation induced by a MAO inhibitor and reserpine in the mouse. Neuropharmacology (1976) 0.77
T cell unresponsiveness in vitro can be due to activation in vivo. Int Immunol (1998) 0.77
Oral administration of antigen can lead to the onset of autoimmune disease. Int Rev Immunol (1999) 0.77
Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration. Kidney Int (2001) 0.76
Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry (1991) 0.76
Delayed onset of action of antidepressant drugs? Survey of recent results. Eur Psychiatry (1997) 0.75
The development and the extinction of hyperthermia induced by conditioned avoidance behavior in rats. J Exp Anal Behav (1970) 0.75
Moclobemide versus fluoxetine for double depression: a randomized double-blind study. J Psychiatr Res (1997) 0.75
Septo-hippocampal system: target for substituted benzamides. Eur J Pharmacol (1982) 0.75
Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressant. Adv Biochem Psychopharmacol (1982) 0.75
Health care's future: the impact of women. J Am Med Rec Assoc (1987) 0.75
Influence of amphetamine and scopolamine on the catalepsy induced by diencephalic lesions in rats. Int J Neuropharmacol (1968) 0.75
Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake. Arzneimittelforschung (1986) 0.75
Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin. Pharmacol Biochem Behav (1983) 0.75
Drug-induced suppression of conditioned hyperthermic and conditioned avoidance behavior response in rats. Psychopharmacologia (1971) 0.75
New pharmacological findings in depression. Psychopathology (1986) 0.75
Progress in the psychopharmacology of antidepressants: selective uptake and MAO-inhibitors. Schweiz Arch Neurol Psychiatr (1986) 0.75
Simple behavioral measures of central alpha-adrenoceptor blocking activity of drugs. Pol J Pharmacol Pharm (1985) 0.75
Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion. Eur J Pharmacol (1983) 0.75
[Pharmacological studies on the effect of neuroleptics in animals after single and repeated application]. Arzneimittelforschung (1968) 0.75
[Psychiatry]. Rev Med Suisse (2007) 0.75
Effect of yohimbine and its diastereoisomers on clonidine-induced depression of exploration in the rat. Eur J Pharmacol (1982) 0.75
Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase. Mod Probl Pharmacopsychiatry (1983) 0.75
[Psychobiology of fear]. Schweiz Rundsch Med Prax (1992) 0.75
Non-response to antidepressants: risk factors and therapeutic possibilities. Pharmacopsychiatry (1988) 0.75
Post-thymic T-cell tolerance or indifference: that is the question. Res Immunol (1992) 0.75
Ligand density determines the efficiency of negative selection in the thymus. Transplantation (2001) 0.75
The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats. Pharmacol Biochem Behav (1983) 0.75
Motility is more important than [correction of that] stealth. Trends Immunol (2001) 0.75